388 related articles for article (PubMed ID: 26388462)
21. Personalized Medicine: Cell and Gene Therapy Based on Patient-Specific iPSC-Derived Retinal Pigment Epithelium Cells.
Li Y; Chan L; Nguyen HV; Tsang SH
Adv Exp Med Biol; 2016; 854():549-55. PubMed ID: 26427458
[TBL] [Abstract][Full Text] [Related]
22. Autosomal recessive bestrophinopathy associated with compound heterozygous variants in the BEST1 gene.
Hemptinne C; Willermain F; de Jong C; Postolache L; Postelmans L
Ophthalmic Genet; 2023 Jun; 44(3):318-320. PubMed ID: 36062537
[No Abstract] [Full Text] [Related]
23. Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors.
Zhang K; Liu GH; Yi F; Montserrat N; Hishida T; Esteban CR; Izpisua Belmonte JC
Protein Cell; 2014 Jan; 5(1):48-58. PubMed ID: 24474194
[TBL] [Abstract][Full Text] [Related]
24. S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA.
Koirala A; Makkia RS; Conley SM; Cooper MJ; Naash MI
Hum Mol Genet; 2013 Apr; 22(8):1632-42. PubMed ID: 23335596
[TBL] [Abstract][Full Text] [Related]
25. Pluripotent stem cells: A therapeutic source for age-related macular degeneration.
Parameswaran S; Krishnakumar S
Indian J Ophthalmol; 2017 Mar; 65(3):177-183. PubMed ID: 28440245
[TBL] [Abstract][Full Text] [Related]
26. The identification of small molecules that stimulate retinal pigment epithelial cells: potential novel therapeutic options for treating retinopathies.
Artero-Castro A; Popelka S; Jendelova P; Motlik J; Ardan T; Rodriguez Jimenez FJ; Erceg S
Expert Opin Drug Discov; 2019 Feb; 14(2):169-177. PubMed ID: 30616395
[TBL] [Abstract][Full Text] [Related]
27. Bringing the age-related macular degeneration high-risk allele age-related maculopathy susceptibility 2 into focus with stem cell technology.
Sun S; Li Z; Glencer P; Cai B; Zhang X; Yang J; Li X
Stem Cell Res Ther; 2017 Jun; 8(1):135. PubMed ID: 28583181
[TBL] [Abstract][Full Text] [Related]
28. Bestrophin-1 influences transepithelial electrical properties and Ca2+ signaling in human retinal pigment epithelium.
Marmorstein AD; Kinnick TR; Stanton JB; Johnson AA; Lynch RM; Marmorstein LY
Mol Vis; 2015; 21():347-59. PubMed ID: 25878489
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Macular Changes in the First Proband of Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) Due to a Newly Identified Mutation in BEST1.
Chen CJ; Kaufman S; Packo K; Stöhr H; Weber BH; Goldberg MF
Ophthalmic Genet; 2016; 37(1):102-8. PubMed ID: 26849243
[TBL] [Abstract][Full Text] [Related]
30. Fundus Autofluorescence and SD-OCT Document Rapid Progression in Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) Associated with a c.256G > A Mutation in BEST1.
Kellner S; Stöhr H; Fiebig B; Weinitz S; Farmand G; Kellner U; Weber BH
Ophthalmic Genet; 2016 Jun; 37(2):201-8. PubMed ID: 26771239
[TBL] [Abstract][Full Text] [Related]
31. CLINICAL PROGRESS IN INHERITED RETINAL DEGENERATIONS: GENE THERAPY CLINICAL TRIALS AND ADVANCES IN GENETIC SEQUENCING.
Hafler BP
Retina; 2017 Mar; 37(3):417-423. PubMed ID: 27753762
[TBL] [Abstract][Full Text] [Related]
32. [Retinal regeneration with iPS cells ‒ Clinical trials for retinal degenerative disorders].
Sugita S
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(2):79-85. PubMed ID: 26016634
[TBL] [Abstract][Full Text] [Related]
33. Ocular phenotype analysis of a family with biallelic mutations in the BEST1 gene.
Sharon D; Al-Hamdani S; Engelsberg K; Mizrahi-Meissonnier L; Obolensky A; Banin E; Sander B; Jensen H; Larsen M; Schatz P
Am J Ophthalmol; 2014 Mar; 157(3):697-709.e1-2. PubMed ID: 24345323
[TBL] [Abstract][Full Text] [Related]
34. [Autosomal recessive bestrophinopathy (ARB): a clinical and molecular description of two patients at childhood].
Preising MN; Pasquay C; Friedburg C; Bowl W; Jäger M; Andrassi-Darida M; Lorenz B
Klin Monbl Augenheilkd; 2012 Oct; 229(10):1009-17. PubMed ID: 23096145
[TBL] [Abstract][Full Text] [Related]
35. BEST1 expression in the retinal pigment epithelium is modulated by OTX family members.
Esumi N; Kachi S; Hackler L; Masuda T; Yang Z; Campochiaro PA; Zack DJ
Hum Mol Genet; 2009 Jan; 18(1):128-41. PubMed ID: 18849347
[TBL] [Abstract][Full Text] [Related]
36. Disease-causing mutations associated with bestrophinopathies promote apoptosis in retinal pigment epithelium cells.
Gao T; Tian C; Xu H; Tang X; Huang L; Zhao M
Graefes Arch Clin Exp Ophthalmol; 2020 Oct; 258(10):2251-2261. PubMed ID: 32507900
[TBL] [Abstract][Full Text] [Related]
37. Protective Effects of Human iPS-Derived Retinal Pigmented Epithelial Cells in Comparison with Human Mesenchymal Stromal Cells and Human Neural Stem Cells on the Degenerating Retina in rd1 mice.
Sun J; Mandai M; Kamao H; Hashiguchi T; Shikamura M; Kawamata S; Sugita S; Takahashi M
Stem Cells; 2015 May; 33(5):1543-53. PubMed ID: 25728228
[TBL] [Abstract][Full Text] [Related]
38. The consortium project to treat RPE65 deficiency in humans.
Hauswirth WW
Retina; 2005 Dec; 25(8 Suppl):S60. PubMed ID: 16374340
[No Abstract] [Full Text] [Related]
39. Gene Therapy for MERTK-Associated Retinal Degenerations.
LaVail MM; Yasumura D; Matthes MT; Yang H; Hauswirth WW; Deng WT; Vollrath D
Adv Exp Med Biol; 2016; 854():487-93. PubMed ID: 26427450
[TBL] [Abstract][Full Text] [Related]
40. Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.
Leach LL; Clegg DO
Stem Cells; 2015 Aug; 33(8):2363-73. PubMed ID: 25809736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
